INTRODUCTION: Dyslipidemia as a modifiable risk factor for chronic non-communicable diseases has become a worldwide concern. We aim to explore different anthropometric measures as predictors of dyslipidemia using various machine learning methods.
CanAssist Breast (CAB), an immunohistochemistry (IHC) and artificial intelligence-based prognostic test, was developed on Hormone receptor-positive (HR +), HER2/neu-negative (HER2-) breast tumors from Indian patients and validated in retrospective gl...
Sepsis is a condition resulting from the uncontrolled immune response to infection, leading to widespread inflammatory damage and potentially fatal organ dysfunction. Currently, there is a lack of specific prevention and treatment strategies for seps...
Cancer remains one of the leading causes of mortality worldwide, where early detection significantly improves patient outcomes and reduces treatment burden. This study investigates the application of Machine Learning (ML) techniques to predict cancer...
Generative Artificial Intelligence (Gen-AI) systems offer significant opportunities for personalized learning in higher education. Studying the effects of personality traits on the use of Gen-AI is crucial for understanding the role of individual dif...
Large language models (LLMs) are the engines behind generative Artificial Intelligence (AI) applications, the most well-known being chatbots. As conversational agents, they-much like the humans on whose data they are trained-exhibit social bias. The ...
Longitudinal serological proteomic dynamics during antiviral therapy (AVT) in chronic hepatitis B (CHB) patients with liver fibrosis remain poorly characterized. Here, using four-dimensional data-independent acquisition mass spectrometry (4D-DIA-MS),...
Spinal nerve sheath tumors are slow-growing neoplasms that arise from Schwann cell lineage and encompass schwannomas, neurofibromas, hybrid nerve sheath tumors, and malignant peripheral nerve sheath tumors. These lesions most commonly present as intr...
The relationship between interleukin-22 and clinical characteristics of patients with inflammatory bowel disease is uncertain. We sought to determine whether plasma interleukin-22 concentrations are associated with disease activity in a large populat...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.